Literature DB >> 21431900

The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease.

Shino Tokiwa1, Satoru Muto, Toshiyuki China, Shigeo Horie.   

Abstract

BACKGROUND: In patients with autosomal dominant polycystic kidney disease (ADPKD), renal cysts grow exponentially. Since remaining renal parenchyma has a capacity to compensate for the loss of glomerular filtration, the glomerular filtration rate (GFR) may be sustained until the disease progresses. The purpose of this study was to determine if renal volumetric indices and clinical parameters are associated with renal function in Japanese patients with ADPKD.
METHODS: In 73 ADPKD patients (28 men, 45 women), the associations of mean systolic blood pressure, mean diastolic blood pressure, estimated GFR (eGFR), the amount of proteinuria and albuminuria, body mass index (BMI), brachial-ankle pulse wave velocity (baPWV), ankle-brachial index, and total kidney volume (TKV) were retrospectively analyzed.
RESULTS: Multivariate linear regression analysis showed that eGFR was significantly and independently inversely correlated with patients' age and BMI. The median change in eGFR per year (ΔeGFR/y) was -2.8 ml/min/1.73 m(2)/year. Multiple linear regression analysis showed that ΔeGFR/y was significantly and independently inversely correlated with the change in TKV per year (ΔTKV/y). Multiple linear regression analysis showed that ΔTKV/y was significantly related to initial TKV and the change in albuminuria per year.
CONCLUSIONS: This study demonstrated a significant relationship between the change in renal function and the change in renal volume in Japanese ADPKD patients without renal insufficiency. It is possible that the volume measurements can be used as useful markers for disease progression in Japanese ADPKD patients.

Entities:  

Mesh:

Year:  2011        PMID: 21431900     DOI: 10.1007/s10157-011-0428-y

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  23 in total

1.  Reliability of magnetic resonance imaging for measuring the volumetric indices in autosomal-dominant polycystic kidney disease: correlation with hypertension and renal function.

Authors:  Young Rae Lee; Kyu-Beck Lee
Journal:  Nephron Clin Pract       Date:  2006-04-24

2.  Imaging progression in polycystic kidney disease.

Authors:  Ronald Perrone
Journal:  N Engl J Med       Date:  2006-05-18       Impact factor: 91.245

Review 3.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

4.  Progression of autosomal-dominant polycystic kidney disease in children.

Authors:  G M Fick-Brosnahan; Z V Tran; A M Johnson; J D Strain; P A Gabow
Journal:  Kidney Int       Date:  2001-05       Impact factor: 10.612

5.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.

Authors:  P A Gabow; A M Johnson; W D Kaehny; W J Kimberling; D C Lezotte; I T Duley; R H Jones
Journal:  Kidney Int       Date:  1992-05       Impact factor: 10.612

6.  Volumetric determination of progression in autosomal dominant polycystic kidney disease by computed tomography.

Authors:  C Sise; M Kusaka; L H Wetzel; F Winklhofer; B D Cowley; L T Cook; M Gordon; J J Grantham
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

7.  Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease.

Authors:  K T Bae; P K Commean; J Lee
Journal:  J Comput Assist Tomogr       Date:  2000 Jul-Aug       Impact factor: 1.826

8.  Prospective change in renal volume and function in children with ADPKD.

Authors:  Melissa A Cadnapaphornchai; Kim McFann; John D Strain; Amirali Masoumi; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2009-04       Impact factor: 8.237

9.  Sirolimus reduces polycystic liver volume in ADPKD patients.

Authors:  Qi Qian; Hui Du; Bernard F King; Sumedha Kumar; Patrick G Dean; Fernando G Cosio; Vicente E Torres
Journal:  J Am Soc Nephrol       Date:  2008-01-16       Impact factor: 10.121

10.  Revised equations for estimated GFR from serum creatinine in Japan.

Authors:  Seiichi Matsuo; Enyu Imai; Masaru Horio; Yoshinari Yasuda; Kimio Tomita; Kosaku Nitta; Kunihiro Yamagata; Yasuhiko Tomino; Hitoshi Yokoyama; Akira Hishida
Journal:  Am J Kidney Dis       Date:  2009-04-01       Impact factor: 8.860

View more
  15 in total

1.  Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Jared J Grantham; Larry T Cook; Vicente E Torres; Arlene B Chapman; Kyongtae Ty Bae; Michal Mrug; Peter C Harris; Frederic F Rahbari-Oskoui; Tiange Shi; William M Bennett
Journal:  Kidney Int       Date:  2019-03-04       Impact factor: 10.612

2.  Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Alan S L Yu; Chengli Shen; Douglas P Landsittel; Peter C Harris; Vicente E Torres; Michal Mrug; Kyongtae T Bae; Jared J Grantham; Frederic F Rahbari-Oskoui; Michael F Flessner; William M Bennett; Arlene B Chapman
Journal:  Kidney Int       Date:  2017-12-28       Impact factor: 10.612

3.  Exploring urinary biomarkers in autosomal dominant polycystic kidney disease.

Authors:  Haruna Kawano; Satoru Muto; Yasukazu Ohmoto; Fusako Iwata; Hiroyuki Fujiki; Toyoki Mori; Lu Yan; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2014-12-28       Impact factor: 2.801

4.  Association of arginine vasopressin surrogate marker urinary copeptin with severity of autosomal dominant polycystic kidney disease (ADPKD).

Authors:  Akiko Nakajima; Yan Lu; Haruna Kawano; Shigeo Horie; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2015-02-27       Impact factor: 2.801

5.  Cost-effectiveness of tolvaptan in autosomal dominant polycystic kidney disease.

Authors:  Kevin F Erickson; Glenn M Chertow; Jeremy D Goldhaber-Fiebert
Journal:  Ann Intern Med       Date:  2013-09-17       Impact factor: 25.391

Review 6.  The importance of total kidney volume in evaluating progression of polycystic kidney disease.

Authors:  Jared J Grantham; Vicente E Torres
Journal:  Nat Rev Nephrol       Date:  2016-10-03       Impact factor: 28.314

7.  Maximal kidney length predicts need for native nephrectomy in ADPKD patients undergoing renal transplantation.

Authors:  Octav Cristea; Daniel Yanko; Sarah Felbel; Andrew House; Alp Sener; Patrick P W Luke
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

8.  Novel semi-automated kidney volume measurements in autosomal dominant polycystic kidney disease.

Authors:  Satoru Muto; Haruna Kawano; Shuji Isotani; Hisamitsu Ide; Shigeo Horie
Journal:  Clin Exp Nephrol       Date:  2017-11-03       Impact factor: 2.801

Review 9.  Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies.

Authors:  Toshio Mochizuki; Ken Tsuchiya; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2012-11-29       Impact factor: 2.801

10.  Factors predicting decline in renal function and kidney volume growth in autosomal dominant polycystic kidney disease: a prospective cohort study (Japanese Polycystic Kidney Disease registry: J-PKD).

Authors:  Kiyotaka Uchiyama; Toshio Mochizuki; Yosuke Shimada; Saori Nishio; Hiroshi Kataoka; Michihiro Mitobe; Ken Tsuchiya; Kazushige Hanaoka; Yoshifumi Ubara; Tatsuya Suwabe; Akinari Sekine; Kikuo Nutahara; Kazuhiko Tsuruya; Eiji Ishimura; Shinya Nakatani; Tadashi Sofue; Satoshi Tanaka; Ichiei Narita; Shoichi Maruyama; Shigeo Horie; Satoru Muto
Journal:  Clin Exp Nephrol       Date:  2021-04-29       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.